Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

BACKGROUND Norepinephrine and glutamate are among several neurotransmitters implicated in the neuropathology of major depressive disorder (MDD). Glia deficits have also been demonstrated in people with MDD, and glia are critical modulators of central glutamatergic transmission. We studied glia in men with MDD in the region of the brain (locus coeruleus; LC) where noradrenergic neuronal cell bodies reside and receive glutamatergic input. METHODS The expression of 3 glutamate-related genes (SLC1A3, SLC1A2, GLUL) concentrated in glia and a glia gene (GFAP) were measured in postmortem tissues from men with MDD and from paired psychiatrically healthy controls. Initial gene expression analysis of RNA isolated from homogenized tissue (n = 9-10 pairs) containing the LC were followed by detailed analysis of gene expressions in astrocytes and oligodendrocytes (n = 6-7 pairs) laser captured from the LC region. We assessed protein changes in GFAP using immunohistochemistry and immunoblotting (n = 7-14 pairs). RESULTS Astrocytes, but not oligodendrocytes, demonstrated robust reductions in the expression of SLC1A3 and SLC1A2, whereas GLUL expression was unchanged. GFAP expression was lower in astrocytes, and we confirmed reduced GFAP protein in the LC using immunostaining methods. LIMITATIONS Reduced expression of protein products of SLC1A3 and SLC1A2 could not be confirmed because of insufficient amounts of LC tissue for these assays. Whether gene expression abnormalities were associated with only MDD and not with suicide could not be confirmed because most of the decedents who had MDD died by suicide. CONCLUSION Major depressive disorder is associated with unhealthy astrocytes in the noradrenergic LC, characterized here by a reduction in astrocyte glutamate transporter expression. These findings suggest that increased glutamatergic activity in the LC occurs in men with MDD.

[1]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[2]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[3]  W. T. Nickell,et al.  The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. , 1986, Science.

[4]  Takeshi Yamada,et al.  Short communication Correlation between plasma levels of glutamate, alanine and serine with severity of depression , 2006 .

[5]  G. Rajkowska,et al.  Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression , 2004, Neuropsychopharmacology.

[6]  M. Pfaffl,et al.  Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR , 2006, Biotechnology Letters.

[7]  T. Fahrig,et al.  Receptor subtype involved and mechanism of norepinephrine‐induced stimulation of glutamate uptake into primary cultures of rat brain astrocytes , 1993, Glia.

[8]  J. O'Brien,et al.  Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[9]  H. Kornhuber,et al.  Increased serum glutamate in depressed patients , 2004, Archiv für Psychiatrie und Nervenkrankheiten.

[10]  C. Stockmeier,et al.  Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in Depression , 2005, Neuropsychopharmacology.

[11]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[12]  P. Duberstein,et al.  The validity of proxy‐based data in suicide research: a study of patients 50 years of age and older who attempted suicide.
I. Psychiatric diagnoses , 2001, Acta psychiatrica Scandinavica.

[13]  G. Ordway.  Brain Norepinephrine: Neuropathology of central norepinephrine in psychiatric disorders: postmortem research , 2007 .

[14]  L. Hösli,et al.  Evidence for the existence of α- and β-adrenoceptors on cultured glial cells—an electrophysiological study , 1982, Neuroscience.

[15]  T. Kelly,et al.  Validity of DSM‐III‐R diagnosis by psychological autopsy: a comparison with clinician ante‐mortem diagnosis , 1996, Acta psychiatrica Scandinavica.

[16]  P Riederer,et al.  Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[17]  D. O'Malley,et al.  Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression , 2009, Neuroscience.

[18]  E. Hansson,et al.  Adrenergic receptor regulation of amino acid neurotransmitter uptake in astrocytes , 1992, Brain Research Bulletin.

[19]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[20]  N. Singewald,et al.  Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress , 1995, Brain Research.

[21]  G. Perea,et al.  GLIA modulates synaptic transmission , 2010, Brain Research Reviews.

[22]  M. Gobbi,et al.  Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. , 2008, European journal of pharmacology.

[23]  Peter J. Munson,et al.  Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Saksida,et al.  Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia , 2009, Neuropsychopharmacology.

[25]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[26]  Y. Mineur,et al.  Antidepressant-Like Effects of Ceftriaxone in Male C57BL/6J Mice , 2007, Biological Psychiatry.

[27]  M. Alda,et al.  Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. , 2005, The American journal of psychiatry.

[28]  R. Baloh,et al.  Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures , 2005, Neurology.

[29]  P. Fisher,et al.  Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes* , 2008, Journal of Biological Chemistry.

[30]  David A. Morilak,et al.  Role of brain norepinephrine in the behavioral response to stress , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  M. Banasr,et al.  Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors , 2008, Biological Psychiatry.

[32]  Maurizio Fava,et al.  The STAR*D project results: A comprehensive review of findings , 2007, Current psychiatry reports.

[33]  H. Meltzer,et al.  Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression , 1999, Brain Research.

[34]  S. Rapoport,et al.  RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. , 2012, Journal of affective disorders.

[35]  B. Cohen,et al.  Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory , 2010, Neuropsychopharmacology.

[36]  S. Dessus-Babus,et al.  Gene expression analyses of neurons, astrocytes, and oligodendrocytes isolated by laser capture microdissection from human brain: Detrimental effects of laboratory humidity , 2009, Journal of neuroscience research.

[37]  B. Roth,et al.  Low nNOS protein in the locus coeruleus in major depression , 2004, Journal of neurochemistry.

[38]  James C. Overholser,et al.  Cellular changes in the postmortem hippocampus in major depression , 2004, Biological Psychiatry.

[39]  Paul J. Harrison,et al.  A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. , 2011, Journal of affective disorders.

[40]  G. Turecki,et al.  Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression. , 2012, The international journal of neuropsychopharmacology.

[41]  P. Duberstein,et al.  The validity of proxy‐based data in suicide research: a study of patients 50 years
of age and older who attempted suicide. 
II. Life events, social support and suicidal behavior , 2001, Acta psychiatrica Scandinavica.

[42]  L. Hösli,et al.  Evidence for the existence of alpha- and beta-adrenoceptors on cultured glial cells--an electrophysiological study. , 1982, Neuroscience.

[43]  I. Gottesman,et al.  Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia , 2004, Schizophrenia Research.

[44]  G. Bartzokis,et al.  Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. , 2010, Bipolar disorders.

[45]  E. V. Bockstaele,et al.  Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region , 2001, Neuroscience.

[46]  V. Klimek,et al.  Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression. , 2003, Journal of psychiatric research.

[47]  J. Kalbfleisch,et al.  Dopamine receptor gene expression in human amygdaloid nuclei: Elevated D4 receptor mRNA in major depression , 2008, Brain Research.

[48]  Robert C. Thompson,et al.  Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression , 2010, Molecular Psychiatry.

[49]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[50]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[52]  G. Rajkowska,et al.  Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. , 2010, Journal of affective disorders.

[53]  J. Janosky,et al.  Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide , 2002, Neuroscience.

[54]  K. Behar,et al.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole , 2010, Molecular Psychiatry.

[55]  D. Pitt,et al.  Glutamate uptake by oligodendrocytes , 2003, Neurology.

[56]  K. Hashimoto,et al.  Increased Levels of Glutamate in Brains from Patients with Mood Disorders , 2007, Biological Psychiatry.